dr lal pathlabs

healthcare stocks to buy: HDFC Securities initiates coverage on these 5 healthcare stocks that can surge up to 20% – In Pink Of Health​

by
healthcare stocks to buy: HDFC Securities initiates coverage on these 5 healthcare stocks that can surge up to 20% – In Pink Of Health​

May 23, 2024, 10:00:31 AM IST ​Domestic brokerage firm HDFC Securities has initiated coverage on several healthcare stocks. It sees a strong potential for value unlocking in these companies, which includes Apollo Hospitals Enterprise and Dr Lal Pathlabs. Here is a list of 5 healthcare stocks on which HDFC Securities initiated coverage: IANS 2/6 ​Max … Read more

hdfc bank shares: Hot Stocks: Brokerage view on Indigo, HDFC Bank, Godrej Consumer and Dr Lal PathLabs

by
hdfc bank shares: Hot Stocks: Brokerage view on Indigo, HDFC Bank, Godrej Consumer and Dr Lal PathLabs

Brokerage firm Kotak Institutional Equities upgraded Dr. Lal PathLabs, Investec maintained a buy rating on Godrej Consumer, CLSA maintained an outperform rating on HDFC Bank and Jefferies upgraded InterGlobe Aviation to hold. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Kotak Institutional Equities on Dr Lal PathLabs: … Read more

Hot Stocks: Brokerages on HDFC Bank, RIL, Dr Lal PathLabs and Shriram Finance

by
Hot Stocks: Brokerages on HDFC Bank, RIL, Dr Lal PathLabs and Shriram Finance

Brokerage Jefferies initiated coverage with a buy rating on Shriram Finance while UBS maintained a buy rating on Dr Lal PathLabs and Reliance Industries. Bernstein has an outperform rating on HDFC Bank. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Jefferies on Shriram Finance: Buy| Target Rs … Read more

stock recommendations: Hot Stocks: Brokerages view on Indian Hotels, Titan Company, Paytm and Dr Lal PathLabs

by
stock recommendations: Hot Stocks: Brokerages view on Indian Hotels, Titan Company, Paytm and Dr Lal PathLabs

Brokerage Goldman Sachs maintained a sell rating on Dr Lal PathLabs, JPMorgan downgraded Paytm to underweight, and Jefferies maintained a hold rating on Titan Company and a buy on Indian Hotels. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Goldman Sachs on Dr Lal PathLabs: Sell| Target … Read more

8 stocks from BNP Paribas’ top picks that have over 20% upside scope – Stock Ideas

by
8 stocks from BNP Paribas’ top picks that have over 20% upside scope – Stock Ideas

Oil And Natural Gas Corporation. Share Price 242.05 04:00 PM | 19 Jan 2024 8.50(3.64%) Bharti Airtel. Share Price 1125.00 03:59 PM | 19 Jan 2024 37.96(3.50%) NTPC. Share Price 308.45 03:58 PM | 19 Jan 2024 9.15(3.06%) Tech Mahindra. Share Price 1389.90 03:59 PM | 19 Jan 2024 34.75(2.57%) SBI Life Insurance Company. Share … Read more

Stocks that India’s top 5 mutual funds bought and sold last month

by
Stocks that India’s top 5 mutual funds bought and sold last month

With Nifty in a consolidating trajectory after hitting the 20,000-milestone in September, mutual funds are using the fresh inflow of funds to pick stocks from sectors like auto, utilities, consumer and insurance. AMFI data shows that money managers reduced stake in banks, IT, capital goods and metals in October. While the weight of private banks … Read more